Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04427033
Other study ID # 2019BB005
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 6, 2019
Est. completion date January 18, 2024

Study information

Verified date January 2024
Source MED-EL Elektromedizinische Geräte GesmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Bonebridge system using the BCI 601 is marketed since 2012. Previous prospective, multi-center, non-randomized studies on the BCI 601 Bonebridge performed in adult and paediatric populations have shown a significant improvement in terms of aided sound field (SF) thresholds, word recognition scores (WRS), speech reception thresholds (SRT) and subjective device satisfaction. Safety was established by stable residual hearing and low complication rates. The Bonebridge, implanted in over 600 clinics worldwide, is the world's first active transcutaneous bone conduction implant (BCI) system. This study now focuses on the further developed BCI 602 (marketed since 2019) that has the same indication criteria and performance characteristics. The aim of this post-market clinical follow-up (PMCF) study is to provide clinical data for the long-term performance and safety when implanted with the Bonebridge BCI 602 .


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date January 18, 2024
Est. primary completion date January 18, 2024
Accepts healthy volunteers No
Gender All
Age group 5 Years and older
Eligibility Inclusion Criteria: - Geographically and physically able to return to the investigational site for scheduled evaluations and follow-up appointments - Fluent in the language used in the investigational site and used for evaluation - Signed and dated informed consent before the start of any study-specific procedure and collection of any retrospective data. - Subjects meet the indication criteria according to the instructions for use (IFU): - Subject 5 years of age and older - The physician must fully assess the potential risks and benefits for the patient and his/her realistic expectations with the device prior to the decision to implant the BCI 602. The physician must exercise medical judgement and consider the patient's complete medical history. - Bonebridge candidates suffer from either - • conductive or mixed hearing loss as indicated by audiometric testing with bone conduction thresholds better than or equal to 45 dB HL at 0.5, 1.0, 2.0 and 3.0 kHz. - • single-sided sensorineural deafness, that is severe-to-profound sensorineural hearing loss in one ear while the other ear has normal hearing (air conduction (AC) should be better than or equal to 20 dB HL measured at 0.5, 1.0, 2.0 and 3.0 kHz). Exclusion Criteria: - A subject whose hearing loss has demonstrated an improving and decreasing fluctuation over a two-year period of >15 dB HL in either direction - Severe, chronic, non-revisable diseases or disorders (vestibular disorder, cancer etc.) - A subject with any psychological (anxiety, depression, hallucinations etc.), emotional (schizophrenia, mania, melancholia etc.) or from that originating physical disorder that would interfere with the ability to perform on test procedures - Simultaneous participation in another clinical trial (on device or on drug) which would interfere with the results of the study. - Any active ear infection - Subjects who meet any of the contraindications in the IFU: - Evidence that hearing loss is of retrocochlear or central origin (ipsilateral CHL /MHL; contralateral SSD) - Skin or scalp conditions that may preclude attachment of the Audio Processor (AP) or that may interfere with the use of the AP - Skull size or abnormality would preclude appropriate placement of the BCI 602 implant - Intolerant to the materials in the BCI 602 implant.

Study Design


Intervention

Device:
Bone Conduction Implant
Bonebridge system BCI 602

Locations

Country Name City State
Austria Universitätsklinik Innsbruck für Hals-, Nasen- und Ohrenheilkunde Innsbruck
Austria Universitätsklinikum St. Pölten - Lilienfeld, Hals-Nasen-Ohren-Abteilung St. Pölten
Austria Klinikum Wels-Grieskirchen, Abteilung für Hals-, Nasen-, Ohrenkrankheiten Wels
Austria Allgemeines Krankenhaus der Stadt Wien, Universitätsklinik für Hals-, Nasen- und Ohrenkrankheiten Wien
Germany Universitätsklinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie Halle/Saale
Germany Klinik u. Poliklinik f. HNO-Heilkunde Hannover
Germany Klinikum Stuttgart - Olgahospital, Klinik für HNO-Krankheiten, Plastische Operationen Stuttgart
United Kingdom Regional Auditory Implant Centre, Beech Hall Centre, Belfast HSC Trust Belfast

Sponsors (1)

Lead Sponsor Collaborator
MED-EL Elektromedizinische Geräte GesmbH

Countries where clinical trial is conducted

Austria,  Germany,  United Kingdom, 

References & Publications (3)

Baumgartner WD, Hamzavi JS, Boheim K, Wolf-Magele A, Schlogel M, Riechelmann H, Zorowka P, Koci V, Keck T, Potzinger P, Sprinzl G. A New Transcutaneous Bone Conduction Hearing Implant: Short-term Safety and Efficacy in Children. Otol Neurotol. 2016 Jul;37(6):713-20. doi: 10.1097/MAO.0000000000001038. — View Citation

Sprinzl G, Lenarz T, Ernst A, Hagen R, Wolf-Magele A, Mojallal H, Todt I, Mlynski R, Wolframm MD. First European multicenter results with a new transcutaneous bone conduction hearing implant system: short-term safety and efficacy. Otol Neurotol. 2013 Aug;34(6):1076-83. doi: 10.1097/MAO.0b013e31828bb541. — View Citation

Sprinzl G, Toner J, Koitschev A, Berger N, Keintzel T, Rasse T, Baumgartner WD, Honeder C, Magele A, Plontke S, Gotze G, Schmutzhard J, Zelger P, Corkill S, Lenarz T, Salcher R. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant. Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1565-1579. doi: 10.1007/s00405-022-07792-y. Epub 2023 Jan 10. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sound Field audiometry Investigate if the PTA4 sound field thresholds (SF) improve with the BCI 602 (aided) at 12 months post-operative compared to the unaided test situation.
(PTA4 = average of audiometric test frequencies 0.5, 1.0, 2.0, 4.0 kHz)
12 months post-operative
Secondary Word Recognition Score (CHL/MHL) Investigate if speech intelligibility improves with the BCI 602 (aided) at 12 months post-operative compared to the unaided test situation in the following speech intelligibility test.
Word Recognition Score (WRS): S0°, WRS correct @ 65 dB SPL Signal
Monosyllabic (MS) word lists are presented from the front (0°) at 65 dB SPL (45 dB HL) and the percent correct score [%] (0 % to 100 %) is recorded.
(SPL= Sound Pressure Level; Score: 0% to 100% words understood )
12 months post-operative
Secondary Speech Reception Threshold in quiet (CHL/MHL) Investigate if speech intelligibility improves with the BCI 602 (aided) in CHL/MHL at 12 months post-operative compared to the unaided test situation in the following speech intelligibility test.
Speech Reception Threshold in quiet (SRT) : S0°, SRT for 50% correct
12 months post-operative
Secondary Speech Reception Threshold in noise (CHL/MHL) Investigate if speech intelligibility improves with the BCI 602 (aided) in CHL/MHL at 12 months post-operative compared to the unaided test situation in the following speech intelligibility test.
Speech Reception Threshold in noise (SNR): S0° N0°, SNR for 50% correct @ 65 dB SPL Noise
12 months post-operative
Secondary Speech Reception Threshold in noise (SSD) Sssd Nnh Investigate if speech intelligibility improves with the BCI 602 (aided) in SSD at 12 months post-operative compared to the unaided test situation in the following speech intelligibility tests.
Sssd Nnh, SNR for 50% correct @ 65 dB SPL Noise
(S= Signal; N= Noise; ssd = single sided deaf ear; nh = normal hearing ear)
12 months post-operative
Secondary Speech Reception Threshold in noise (SSD) S0° Nnh Investigate if speech intelligibility improves with the BCI 602 (aided) in SSD at 12 months post-operative compared to the unaided test situation in the following speech intelligibility tests.
S0° Nnh, SNR for 50% correct @ 65 dB SPL Noise
12 months post-operative
Secondary Residual hearing Investigate whether residual hearing by means of bone conduction (BC) PTA4 thresholds of subjects implanted with the BCI 602 remains stable 12 months post-operative compared to the pre operative test situation. 12 months post-operative
Secondary Adverse Events Monitor the long-term safety of subjects implanted with the BCI 602 by collecting and reviewing adverse events (AEs). 12 months post-operative
Secondary Surgical Questionnaires Monitor the long-term safety of subjects implanted with the BCI 602 by administering a surgical evaluation questionnaire to the surgeon. 12 months post-operative
Secondary Speech Spatial Qualities questionnaire Investigate the Quality of Life with the SSQ questionnaire of subjects implanted with the BCI 602 12 months post-operative.
(SSQ = Speech Spatial Qualities)
12 months post-operative
Secondary Assessment Quality of Life questionnaire Investigate the Quality of Life with the AQoL questionnaire of subjects implanted with the BCI 602 12 months post-operative.
(AQoL= Assessment Quality of Life)
12 months post-operative
See also
  Status Clinical Trial Phase
Recruiting NCT04696835 - fNIRS in Pediatric Hearing Aids N/A
Completed NCT03662256 - Reducing Childhood Hearing Loss in Rural Alaska Through a Preschool Screening and Referral Process Using Mobile Health and Telemedicine N/A
Completed NCT04602780 - Evaluating the Revised WORQ in CI Users
Completed NCT03723161 - Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT03428841 - Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients N/A
Completed NCT04559282 - Home Test of New Sound Processor N/A
Enrolling by invitation NCT03345654 - Individually-guided Hearing Aid Fitting
Completed NCT06016335 - MRI-based Synthetic CT Images of the Head and Neck N/A
Completed NCT05165121 - Comparison of Hearing Aid Fitting Outcomes Between Self-fit and Professional Fit for MDHearing Smart Hearing Aids N/A
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed NCT04622059 - AUditive Direct In-utero Observation (AUDIO): Prenatal Testing of Congenital Hypoacusis N/A
Terminated NCT02294812 - Effects of Cognitive Training on Speech Perception N/A
Recruiting NCT02558478 - Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing N/A
Withdrawn NCT02740322 - Validating the Hum Test N/A
Completed NCT01963104 - Community-Based Kiosks for Hearing Screening and Education N/A
Completed NCT01892007 - Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users N/A
Completed NCT01857661 - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial N/A
Withdrawn NCT01223638 - The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism N/A